Moreover, MK-2206 2HCl (a specific inhibitor of AKT) blocked the pro-migration/invasion and pathway-activating effects of UBE2T overexpression in NPC cells. The gene discussed is UBE2T; the disease is nasopharyngeal carcinoma.